Investor
Relations

We are committed to developing transformational biologic medicines to serve patients with debilitating diseases

Presentations

Date	Title
Oct 15, 2021	AMT Corporate Presentation October 2021
Oct 15, 2021	AMT Research & Development Day Presentation